<DOC>
	<DOC>NCT02201940</DOC>
	<brief_summary>The primary objectives of this study are to evaluate the efficacy, safety, and tolerability of sofosbuvir/velpatasvir (SOF/VEL) fixed dose combination (FDC) for 12 weeks in adults with chronic genotype 1, 2, 4, 5, or 6 hepatitis C virus (HCV) infection.</brief_summary>
	<brief_title>Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>Willing and able to provide written informed consent HCV RNA ≥ 10^4 IU/mL at screening HCV genotype 1, 2, 4, 5, 6, or indeterminate assessed at screening by the central laboratory Chronic HCV infection (≥ 6 months) documented by prior medical history or liver biopsy Classification as treatment naive or treatment experienced Males and females of childbearing potential who engage in heterosexual intercourse must agree to use protocol specified method(s) of contraception Current or prior history of clinicallysignificant illness (other than HCV) or any other major medical disorder that may interfere with treatment, assessment, or compliance with the protocol; individuals currently under evaluation for a potentially clinicallysignificant illness (other than HCV) are also excluded. Screening ECG with clinically significant abnormalities Laboratory results outside of acceptable ranges at Screening Prior exposure to SOF or other nucleotide analogue HCV NS5B inhibitor or any HCV NS5A inhibitor Infection with hepatitis B virus (HBV) or human immunodeficiency virus (HIV)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Sofosbuvir</keyword>
	<keyword>SOF/VEL</keyword>
	<keyword>Velpatasvir</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>HCV</keyword>
	<keyword>cirrhosis</keyword>
</DOC>